These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1364 related items for PubMed ID: 19162288

  • 1. [Antibodies in myasthenia gravis].
    Eymard B.
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [Abstract] [Full Text] [Related]

  • 2. [Myasthenia and pregnancy: a clinical and immunologic study of 42 cases (21 neonatal myasthenia cases)].
    Eymard B, Morel E, Dulac O, Moutard-Codou ML, Jeannot E, Harpey JP, Rondot P, Bach JF.
    Rev Neurol (Paris); 1989 Feb; 145(10):696-701. PubMed ID: 2814151
    [Abstract] [Full Text] [Related]

  • 3. Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies.
    Graus YF, de Baets MH, Parren PW, Berrih-Aknin S, Wokke J, van Breda Vriesman PJ, Burton DR.
    J Immunol; 1997 Feb 15; 158(4):1919-29. PubMed ID: 9029134
    [Abstract] [Full Text] [Related]

  • 4. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
    Nikolic A, Djukic P, Basta I, Hajdukovic Lj, Stojanovic VR, Stevic Z, Nikolic D, Bozic V, Lavrnic S, Lavrnic D.
    Clin Neurol Neurosurg; 2013 Apr 15; 115(4):432-7. PubMed ID: 22770539
    [Abstract] [Full Text] [Related]

  • 5. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A, Tonali PA, Padua L, Monaco ML, Scuderi F, Batocchi AP, Marino M, Bartoccioni E.
    Brain; 2003 Oct 15; 126(Pt 10):2304-11. PubMed ID: 12821509
    [Abstract] [Full Text] [Related]

  • 6. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ, Oshima M, Deitiker P.
    Crit Rev Immunol; 2001 Oct 15; 21(1-3):1-27. PubMed ID: 11642597
    [Abstract] [Full Text] [Related]

  • 7. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
    Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A.
    Nat Med; 2001 Mar 15; 7(3):365-8. PubMed ID: 11231638
    [Abstract] [Full Text] [Related]

  • 8. [Acetylcholine receptor antibody titer, sensitivity to curare electromyogram and disease severity in myasthenia gravis].
    Chen SM.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun 15; 24(3):169-73, 189. PubMed ID: 1889330
    [Abstract] [Full Text] [Related]

  • 9. Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera.
    Tzartos SJ, Sophianos D, Efthimiadis A.
    J Immunol; 1985 Apr 15; 134(4):2343-9. PubMed ID: 3973387
    [Abstract] [Full Text] [Related]

  • 10. Antigenic modulation of human myotube acetylcholine receptor by myasthenic sera. Serum titer determines receptor internalization rate.
    Tzartos SJ, Sophianos D, Zimmerman K, Starzinski-Powitz A.
    J Immunol; 1986 May 01; 136(9):3231-8. PubMed ID: 3958494
    [Abstract] [Full Text] [Related]

  • 11. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L, Ranelletti F, Maggiano N, Guerriero M, Punzi C, Marsili F, Bartoccioni E, Evoli A.
    Neurology; 2005 Feb 08; 64(3):536-8. PubMed ID: 15699390
    [Abstract] [Full Text] [Related]

  • 12. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
    Farrugia ME, Robson MD, Clover L, Anslow P, Newsom-Davis J, Kennett R, Hilton-Jones D, Matthews PM, Vincent A.
    Brain; 2006 Jun 08; 129(Pt 6):1481-92. PubMed ID: 16672291
    [Abstract] [Full Text] [Related]

  • 13. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
    Kawanami S, Tsuji R, Oda K.
    Ann Neurol; 1984 Feb 08; 15(2):195-200. PubMed ID: 6367620
    [Abstract] [Full Text] [Related]

  • 14. Sequence analysis of anti-AChR antibodies in experimental autoimmune myasthenia gravis.
    Graus Y, Meng F, Vincent A, van Breda Vriesman P, de Baets M.
    J Immunol; 1995 Jun 15; 154(12):6382-96. PubMed ID: 7539019
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
    Hayashi A, Shiono H, Ohta M, Ohta K, Okumura M, Sawa Y.
    J Neuroimmunol; 2007 Sep 15; 189(1-2):163-8. PubMed ID: 17706794
    [Abstract] [Full Text] [Related]

  • 17. [Autoantibodies detected in acetylcholine receptor antibody-negative myasthenia gravis].
    Ohta R, Motomura M.
    Rinsho Byori; 2014 Mar 15; 62(3):255-60. PubMed ID: 24800501
    [Abstract] [Full Text] [Related]

  • 18. Antimuscle and antiacetylcholine receptor antibodies in myasthenia gravis.
    Penn AS, Schotland DL, Lamme S.
    Muscle Nerve; 1986 Jun 15; 9(5):407-15. PubMed ID: 3724787
    [Abstract] [Full Text] [Related]

  • 19. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN, Reddel SW, Gervásio OL, Phillips WD.
    Ann Neurol; 2008 Jun 15; 63(6):782-9. PubMed ID: 18384168
    [Abstract] [Full Text] [Related]

  • 20. Humoral immunity in myasthenia gravis: biochemical characterization of acquired antireceptor antibodies and clinical correlations.
    Tindall RS.
    Ann Neurol; 1981 Nov 15; 10(5):437-47. PubMed ID: 7305297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 69.